Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
1
×
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
1
×
national top stories
new york blog main
1
×
rare disease drugs
1
×
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
ago
biotechs
considering
data
diseases
drug
dyne
early
expected
experimental
eyes
1
×
genetic
having
humans
ipo
ipos
1
×
long
medicines
muscle
rare
reach
therapeutics
worked
Language
unset
Current search:
ipos
×
photo
×
" rare disease drugs "
×
eyes
×
" new york blog main "
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases